Schoen; Uwe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schoen; Uwe.The latest application filed is for "hepatitis c inhibitors and uses thereof".

Company Profile

0.15.14

Schoen; Uwe - Burgdorf DE
Schoen; Uwe - Neunkirchen DE
SCHOEN; Uwe - Hannover DE
Schoen; Uwe - Rheinfelden DE
Schoen; Uwe - Hanover DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hepatitis C inhibitors and uses thereof Grant 9,567,355 - Maring , et al. February 14, 2	2017-02-14
Hepatitis C Inhibitors And Uses Thereof App 20160355530 - Maring; Clarence J. ; et al.	2016-12-08
Hepatitis C inhibitors and uses thereof Grant 9,453,007 - Maring , et al. September 27, 2	2016-09-27
Hepatitis C Inhibitors And Uses Thereof App 20160002213 - Maring; Clarence J. ; et al.	2016-01-07
Cryogenic storage device Grant 8,925,334 - Zimmermann , et al. January 6, 2	2015-01-06
Hepatitis C Inhibitors And Uses Thereof App 20140038919 - Maring; Clarence J. ; et al.	2014-02-06
Substituted estratriene derivatives as 17BETA HSD inhibitors Grant 8,288,367 - Messinger , et al. October 16, 2	2012-10-16
Therapeutically active triazoles and their use Grant 8,080,540 - Messinger , et al. December 20, 2	2011-12-20
Cryogenic Storage Device App 20110219788 - Zimmermann; Heiko ; et al.	2011-09-15
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions Grant 7,772,225 - Antel , et al. August 10, 2	2010-08-10
NK1 and NK2-antagonists and compositions and methods of using the same Grant 7,592,344 - Antel , et al. September 22, 2	2009-09-22
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof Grant 7,547,708 - Antel , et al. June 16, 2	2009-06-16
Sulfamate Compounds and Uses Thereof App 20090104126 - SCHOEN; Uwe ; et al.	2009-04-23
Substituted Estratriene Derivatives As 17beta Hsd Inhibitors App 20080255075 - MESSINGER; Josef ; et al.	2008-10-16
Therapeutically Active Triazoles and Their Use App 20080146531 - Messinger; Josef ; et al.	2008-06-19
N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions App 20070149512 - Antel; Jochen ; et al.	2007-06-28
NK1 and NK2-antagonists and compositions and methods of using the same App 20070149537 - Antel; Jochen ; et al.	2007-06-28
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof App 20070117823 - Antel; Jochen ; et al.	2007-05-24
Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions App 20050261292 - Antel, Jochen ; et al.	2005-11-24
3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia Grant 6,602,880 - Schoen , et al. August 5, 2	2003-08-05
3-Phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia App 20030109541 - Schoen, Uwe ; et al.	2003-06-12
Process for preparing epoxysilanes Grant 6,402,961 - Bade , et al. June 11, 2	2002-06-11
N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity App 20020065276 - Jasserand, Daniel ; et al.	2002-05-30
Process for preparing 3-glycidyloxypropyltrialkoxysilanes Grant 6,100,408 - Monkiewicz , et al. August 8, 2	2000-08-08
3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane compounds and medicaments containing said compounds Grant 4,906,640 - Schoen , et al. March 6, 1	1990-03-06
Intermediates for synthesizing pharmaceutically active 3,7-diazabicyclo-(3,3,1)-nonane compounds Grant 4,742,172 - Schoen , et al. May 3, 1	1988-05-03
3,7-Diazabicyclo(3,3,1)nonane compounds and their use in treating heart disease Grant 4,550,112 - Schoen , et al. October 29, 1	1985-10-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.